Pillar Pacific Capital Management buys $5,624,900 stake in Monsanto Company (MON)

Monsanto Company (MON) : Pillar Pacific Capital Management scooped up 1,399 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 53,899 shares of Monsanto Company which is valued at $5,624,900.Monsanto Company makes up approximately 0.91% of Pillar Pacific Capital Management’s portfolio.

Other Hedge Funds, Including , Hudock Capital Group reduced its stake in MON by selling 200 shares or 54.5% in the most recent quarter. The Hedge Fund company now holds 167 shares of MON which is valued at $17,428. Monsanto Company makes up approx 0.01% of Hudock Capital Group’s portfolio.Charter Trust Co reduced its stake in MON by selling 128 shares or 1.2% in the most recent quarter. The Hedge Fund company now holds 10,540 shares of MON which is valued at $1,125,250. Monsanto Company makes up approx 0.13% of Charter Trust Co’s portfolio.Sumitomo Life Insurance Co reduced its stake in MON by selling 564 shares or 3.41% in the most recent quarter. The Hedge Fund company now holds 15,981 shares of MON which is valued at $1,701,018. Monsanto Company makes up approx 0.23% of Sumitomo Life Insurance Co’s portfolio. Neville Rodie Shaw Inc sold out all of its stake in MON during the most recent quarter. The investment firm sold 2,445 shares of MON which is valued $247,263.Fisher Asset Management reduced its stake in MON by selling 105 shares or 4.26% in the most recent quarter. The Hedge Fund company now holds 2,360 shares of MON which is valued at $238,667.

Monsanto Company opened for trading at $104.36 and hit $106.94 on the upside on Thursday, eventually ending the session at $106.42, with a gain of 1.97% or 2.06 points. The heightened volatility saw the trading volume jump to 49,51,389 shares. Company has a market cap of $46,567 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.